Defining Burkitt's lymphoma (BL) with cytogenetics: LY10, a prospective clinicopathological study of dose-reduced (dr) CODOX-M/IVAC in patients with 100% Ki-67 staining B-cell non-Hodgkin's lymphoma (NHL).

J. Walewski, G. Mead, A. Jack, S. Barrans, J. Radford, S. Clawson, S. Stenning, W. Qian, Natl Canc Res Inst Lymphoma Gr

    Research output: Contribution to journalMeeting Abstractpeer-review

    Original languageEnglish
    Pages (from-to)436S
    Number of pages1
    JournalJournal of Clinical Oncology
    Volume24
    Issue number18
    Publication statusPublished - 20 Jun 2006
    Event42nd Annual Meeting of the American-Society-of-Clinical-Oncology - Atlanta, United States
    Duration: 2 Jun 20066 Jun 2006

    Cite this